Literature DB >> 2881314

Naloxone blocks the effects of chlordiazepoxide on acquisition but not performance of differential reinforcement of low rates of response (DRL).

G Tripp, N McNaughton, T P Oei.   

Abstract

The opiate antagonist naloxone can completely or partially reverse the effects of the benzodiazepines on appetitive behaviours and conflict tasks involving electric shook. If naloxone changes the anxiolytic action of the benzodiazepines it should theoretically, be effective in tasks employing nonreward as well as those employing shock. We tested naloxone and chlordiazepoxide on acquisition and performance of a nonreward task, DRL. With both continuous administration during acquisition of DRL, and intermittent administration during stable performance, chlordiazepoxide (5 mg/kg IP) increased burst responding and shifted the peak of the inter-response time (IRT) distribution curve to shorter IRTs. Naloxone (3 mg/kg IP) blocked the effects of chlordiazepoxide on acquisition of DRL. Naloxone (3 mg/kg and 10 mg/kg IP) did not change the effects of chlordiazepoxide on well-learned performance of the DRL schedule. These results show that endogenous opiates could mediate some but not all of the actions of the benzodiazepines. They also suggest that state-dependent and "truly anxiolytic" effects of the benzodiazepines (McNaughton 1985) may have different pharmacological substrates.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881314     DOI: 10.1007/bf00690938

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

Review 1.  Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors.

Authors:  S J Cooper; L B Estall
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

2.  Effects of d-amphetamine and chlordiazepoxide on spaced responding in pigeons.

Authors:  D E McMillan; R J Campbell
Journal:  J Exp Anal Behav       Date:  1970-09       Impact factor: 2.468

3.  Comparative neuropharmacology of antianxiety drugs.

Authors:  S M Paul; P Skolnick
Journal:  Pharmacol Biochem Behav       Date:  1982       Impact factor: 3.533

4.  The effects of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines.

Authors:  M L Billingsley; R K Kubena
Journal:  Life Sci       Date:  1978-03       Impact factor: 5.037

5.  Effects of naloxone on the anticonflict properties of alcohol and chlordiazepoxide.

Authors:  G F Koob; R E Strecker; F E Bloom
Journal:  Subst Alcohol Actions Misuse       Date:  1980

6.  Naloxone inhibits diazepam-induced feeding in rats.

Authors:  J M Stapleton; M D Lind; V J Merriman; L D Reid
Journal:  Life Sci       Date:  1979-06-25       Impact factor: 5.037

7.  The effects of tranquillizing drugs on timing behaviour in rats.

Authors:  D J Sanger; D E Blackman
Journal:  Psychopharmacologia       Date:  1975-10-31

8.  Effects of opiate antagonists and of morphine on chlordiazepoxide-induced hyperdipsia in the water-deprived rat.

Authors:  S J Cooper
Journal:  Neuropharmacology       Date:  1982-10       Impact factor: 5.250

9.  Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats.

Authors:  T Duka; R Cumin; W Haefely; A Herz
Journal:  Pharmacol Biochem Behav       Date:  1981-07       Impact factor: 3.533

10.  Differential effects on naloxone against the diazepam-induced release of behavior in rats in three aversive situations.

Authors:  P Soubrié; A Jobert; M H Thiebot
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  2 in total

1.  Naloxone fails to block the effects of chlordiazepoxide on acquisition and performance of successive discrimination.

Authors:  G Tripp; N McNaughton
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Pharmacological dissociation between the spatial learning deficits produced by morphine and diazepam.

Authors:  R K McNamara; R W Skelton
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.